Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02257970 · ClinicalTrials.gov registry record · Phase 4
Lymphedema Study for Arm or Leg Lymphedema
A Phase 4 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 4
- Development phase
- 117
- Enrollment target
NCT02257970: Completed Phase 4 study, sponsored by Stanford University.
NCT02257970 is a Phase 4 study that has completed, run by Stanford University. The registered enrollment target is 117 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02257970, a Phase 4 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 117 participants
- Enrollment target
Study Summary
This study compares the effectiveness of a study drug versus placebo in the treatment of lymphedema.
Interventions
- DRUG Placebo
- DRUG Ketoprofen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2009-03 |
| Est. Completion | 2017-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02257970
The ClinicalTrials.gov registry entry for NCT02257970 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02257970 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02257970 about?
NCT02257970 is a clinical study titled "Lymphedema Study for Arm or Leg Lymphedema". This study compares the effectiveness of a study drug versus placebo in the treatment of lymphedema.
What is the current status of trial NCT02257970?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 117 participants. The study started on 2009-03. Estimated completion is 2017-03.
What interventions are being tested in trial NCT02257970?
The interventions under investigation include: Placebo (DRUG), Ketoprofen (DRUG).
Who is sponsoring clinical trial NCT02257970?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.